On the last day of AGBT, attendees crowded the room for the session everyone had been waiting for: New Genomic Frontiers, highlighting sequencing advances from Pacific Biosciences, Complete Genomics, Life Technologies, Ion Torrent, and Helicos. At Genetic Interference, Luke Jostins gives a quick run-down of each and he notes that "we are starting to see a divergence in sequencing technologies … This means that the scientists themselves can more closely tailor their choice of tech to fit their situation."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.